2010至2017年苏格兰青光眼药物治疗的患病率
该研究基于苏格兰NHS处方信息系统,统计2010至2017年全人群接受降眼压药物治疗的患者数量及人口学分布,并与全国人口普查数据预测的因人口老龄化导致的预期增长进行比较。2017年治疗人数为61 249人(占总人口1.13%,40岁以上人群2.16%),较2010年增加27.13%(年均3.88%),而人口结构变化预期仅增加12.24%,观察增幅为预期的2.22倍。结论认为苏格兰青光眼和高眼压症用药人数持续增加,其增速不能仅用人口规模和年龄结构变化解释。
要点
- 2017年苏格兰接受降眼压药物治疗者61 249人,占总人口1.13%,40岁以上人群2.16%。
- 治疗人数从2010年48 178人增至2017年61 249人,增幅27.13%(年均3.88%)。
- 患病率随年龄增长,90岁以上人群达10.67%;年龄调整后男性治疗多于女性(OR 1.26)。
核心结论
- 苏格兰因青光眼和高眼压症接受药物治疗的患者数量正在增加。
- 该增加速率不能仅用人口规模和年龄结构的变化来解释。
研究设计与样本
- 数据来源于苏格兰NHS信息与统计部门的处方信息系统。
- 收集每个日历年内在社区药房配取任何降眼压药物的患者数量,按性别和5岁年龄组统计。
- 使用全国人口普查数据建模,预测因人口老龄化导致的年治疗人数预期增长。
主要发现
- 2017年治疗患者数为61 249人,占总人口1.13%,40岁以上人群为2.16%。
- 治疗人数从2010年的48 178人增加至2017年的61 249人,增幅27.13%(年均3.88%)。
- 患病率随年龄增长,90岁以上人群达到10.67%。
- 年龄调整后,男性接受治疗多于女性(OR 1.26)。
- 基于人口普查预测的2017年预期治疗人数为54 075人(较2010年增加5897人,增幅12.24%);观察到的27.13%增幅是2010至2017年人口变化预期速率的2.22倍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To report the number and demographic distribution of patients receiving intraocular pressure (IOP)-lowering medications across the whole population of Scotland for the years 2010-2017 and, using national census data, show how the observed changes compare with those predicted by the increasing age of the population structure over this period. METHODS: Data were sourced from the Prescribing Information System of the NHS Information and Statistics Division for Scotland. The number of patients dispensed any IOP-lowering medication from a community pharmacy during each calendar year was collected by gender and by 5-year age bands. National census data were used to model the expected annual increase in treatment numbers due to population ageing. RESULTS: The number of treated patients in 2017 was 61 249 which represents 1.13% of the whole population (or 2.16% over 40 years of age). The number increased from 48 178 in 2010-an increase over this period of 27.13% (3.88% per year).Prevalence increased with age, reaching 10.67% in those over 90 years. After age adjustment, more men were treated than women (OR 1.26).The expected number treated in 2017 based on census predictions was 54 075 (an increase of 5897 (12.24%) from 2010). The observed growth of 27.13% was 2.22-fold greater than the rate expected by population changes over the period 2010-2017. CONCLUSION: The number of patients on medication for glaucoma and ocular hypertension in Scotland is increasing. The rate of increase cannot be explained by changes in the size and age structure of the population alone.
引用
- Rotchford AP, Hughes J, Agarwal PK, et al. Prevalence of treatment with glaucoma medication in Scotland, 2010-2017. Br J Ophthalmol. 2019. PMID: 31097436. doi:10.1136/bjophthalmol-2019-314206
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。